Miriam Ahlborn

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

Peter Borchmann, Annette Plütschow, Carsten Kobe et al. · The Lancet Oncology · 2021 · 168 citations

Medicine, Oncology, Radiology +13

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

Ivonne Haffner, Katrin Schierle, Elba Raimúndez et al. · Journal of Clinical Oncology · 2021 · 123 citations · Full text

Medicine, Oncology, Pharmacology +17

Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course

J. Vogt, Franziska Beyer, J. Sistermanns et al. · The Oncologist · 2021 · 100 citations · Full text

Medicine, Oncology, End-of-life Care +14

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Symptoms and Needs of Patients with Advanced Lung Cancer: Early Prevalence Assessment

Jonas Kuon, J. Vogt, Anja Mehnert et al. · Oncology Research and Treatment · 2019 · 31 citations · Full text

Medicine, Oncology, Cancer Symptom Management +16